Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 20;28(1):54.
doi: 10.1186/s13054-024-04832-3.

Healthcare-associated infections in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort study

Collaborators, Affiliations

Healthcare-associated infections in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort study

Nicolas Nesseler et al. Crit Care. .

Abstract

Background: Both critically ill patients with coronavirus disease 2019 (COVID-19) and patients receiving extracorporeal membrane oxygenation (ECMO) support exhibit a high incidence of healthcare-associated infections (HAI). However, data on incidence, microbiology, resistance patterns, and the impact of HAI on outcomes in patients receiving ECMO for severe COVID-19 remain limited. We aimed to report HAI incidence and microbiology in patients receiving ECMO for severe COVID-19 and to evaluate the impact of ECMO-associated infections (ECMO-AI) on in-hospital mortality.

Methods: For this study, we analyzed data from 701 patients included in the ECMOSARS registry which included COVID-19 patients supported by ECMO in France.

Results: Among 602 analyzed patients for whom HAI and hospital mortality data were available, 214 (36%) had ECMO-AI, resulting in an incidence rate of 27 ECMO-AI per 1000 ECMO days at risk. Of these, 154 patients had bloodstream infection (BSI) and 117 patients had ventilator-associated pneumonia (VAP). The responsible microorganisms were Enterobacteriaceae (34% for BSI and 48% for VAP), Enterococcus species (25% and 6%, respectively) and non-fermenting Gram-negative bacilli (13% and 20%, respectively). Fungal infections were also observed (10% for BSI and 3% for VAP), as were multidrug-resistant organisms (21% and 15%, respectively). Using a Cox multistate model, ECMO-AI were not found associated with hospital death (HR = 1.00 95% CI [0.79-1.26], p = 0.986).

Conclusions: In a nationwide cohort of COVID-19 patients receiving ECMO support, we observed a high incidence of ECMO-AI. ECMO-AI were not found associated with hospital death. Trial registration number NCT04397588 (May 21, 2020).

Keywords: Bloodstream infections; ECLS; Nosocomial infections; SARS-CoV 2; Ventilator-associated pneumonia.

PubMed Disclaimer

Conflict of interest statement

Nicolas NESSELER declares no competing interests. Alexandre MANSOUR received payments made to his institution from i-SEP for consulting fees, and from LFB, Viatris, Aguettant and Pfizer for lecture fees. Matthieu SCHMIDT received consultancy fees from Getinge, Xenios FMC and Drager. Claire FOUGEROU declares no competing interests. James T. ROSS declares no competing interests. Alizée PORTO declares no competing interests. Marylou PARA declares no competing interests. Pierre-Emmanuel FALCOZ declares no competing interests. Nicolas MONGARDON received consultant fees from Amomed and Baxter. Guillaume LEBRETON reports lecture fees from Livanova and Abiomed. Antoine BEURTON declares no competing interests. Lucie GAIDE-CHEVRONNAY declares no competing interests. Erwan FLECHER declares no competing interests. André VINCENTELLI declares no competing interests. Nicolas MASSART declares no competing interests.

Figures

Fig. 1
Fig. 1
Flow chart of ECMO patients included in the study
Fig. 2
Fig. 2
Cumulative ECMO-AI incidence

Similar articles

Cited by

References

    1. Schmidt M, Bréchot N, Hariri S, Guiguet M, Luyt CE, Makri R, et al. Nosocomial Infections in adult cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation. Clin Infect Dis. 2012;55:1633–1641. doi: 10.1093/cid/cis783. - DOI - PMC - PubMed
    1. Grasselli G, Scaravilli V, Bella SD, Biffi S, Bombino M, Patroniti N, et al. Nosocomial infections during extracorporeal membrane oxygenation. Crit Care Med. 2017;45:1726–1733. doi: 10.1097/CCM.0000000000002652. - DOI - PubMed
    1. Vacheron C-H, Lepape A, Savey A, Machut A, Timsit JF, Vanhems P, et al. Increased incidence of ventilator-acquired pneumonia in coronavirus disease 2019 patients: a multicentric cohort study*. Crit Care Med. 2022;50:449–459. doi: 10.1097/CCM.0000000000005297. - DOI - PMC - PubMed
    1. Lepape A, Machut A, Bretonnière C, Friggeri A, Vacheron C-H, Savey A, et al. Effect of SARS-CoV-2 infection and pandemic period on healthcare-associated infections acquired in intensive care units. Clin Microbiol Infect. 2023;29:530–536. doi: 10.1016/j.cmi.2022.10.023. - DOI - PMC - PubMed
    1. Rouzé A, Martin-Loeches I, Povoa P, Makris D, Artigas A, Bouchereau M, et al. Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study. Intensiv Care Med. 2021;47:188–198. doi: 10.1007/s00134-020-06323-9. - DOI - PMC - PubMed

MeSH terms

Associated data